1. Home
  2. NXL vs SGRP Comparison

NXL vs SGRP Comparison

Compare NXL & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • SGRP
  • Stock Information
  • Founded
  • NXL 2010
  • SGRP 1967
  • Country
  • NXL United States
  • SGRP United States
  • Employees
  • NXL N/A
  • SGRP N/A
  • Industry
  • NXL Medical Specialities
  • SGRP Business Services
  • Sector
  • NXL Health Care
  • SGRP Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • SGRP Nasdaq
  • Market Cap
  • NXL 25.1M
  • SGRP 27.3M
  • IPO Year
  • NXL 2022
  • SGRP 1996
  • Fundamental
  • Price
  • NXL $1.24
  • SGRP $1.07
  • Analyst Decision
  • NXL Strong Buy
  • SGRP
  • Analyst Count
  • NXL 1
  • SGRP 0
  • Target Price
  • NXL $5.00
  • SGRP N/A
  • AVG Volume (30 Days)
  • NXL 675.7K
  • SGRP 46.0K
  • Earning Date
  • NXL 11-07-2025
  • SGRP 11-14-2025
  • Dividend Yield
  • NXL N/A
  • SGRP N/A
  • EPS Growth
  • NXL N/A
  • SGRP N/A
  • EPS
  • NXL N/A
  • SGRP N/A
  • Revenue
  • NXL $174,813.00
  • SGRP $143,501,000.00
  • Revenue This Year
  • NXL $38.28
  • SGRP $7.22
  • Revenue Next Year
  • NXL $185.71
  • SGRP N/A
  • P/E Ratio
  • NXL N/A
  • SGRP N/A
  • Revenue Growth
  • NXL 16.42
  • SGRP N/A
  • 52 Week Low
  • NXL $0.70
  • SGRP $0.91
  • 52 Week High
  • NXL $4.49
  • SGRP $2.48
  • Technical
  • Relative Strength Index (RSI)
  • NXL 44.47
  • SGRP 46.98
  • Support Level
  • NXL $1.44
  • SGRP $1.04
  • Resistance Level
  • NXL $1.45
  • SGRP $1.15
  • Average True Range (ATR)
  • NXL 0.13
  • SGRP 0.04
  • MACD
  • NXL -0.05
  • SGRP 0.00
  • Stochastic Oscillator
  • NXL 4.12
  • SGRP 25.62

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

Share on Social Networks: